Analysts Maintain Buy Rating on Rainbow Childrens with INR 1,650 Target Price
Two recent reports from Prabhudas Lilladher and Choice Institutional Equities maintain a 'BUY' rating on Rainbow Childrens Medicare with a target price of INR 1,650. Both highlight the company's ongoing capacity expansion, including new bed additions and clinical hiring, alongside investments in technology and operational efficiencies. They project strong EBITDA and revenue growth through FY29, supported by Rainbow's integrated pediatric hospital model and strategic focus on South India, anticipating improved profitability and patient volumes.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (72/100). Lens Score 25/100.
Outlets measured: moneycontrol, moneycontrol. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (70–75/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
moneycontrol broke this story on 3 Nov, 06:01 am. Other outlets followed.